|
|
Richard D. Palmiter
J Clin Invest. 2009;
119(8):2130
doi:10.1172/JCI40001
Abstract |
Full text
| PDF
T
he level of neurotransmitters present in the synaptic cleft is a function of the delicate balance among neurotransmitter synthesis, recycling, and degradation. While much is known about the processes controlling neurotransmitter synthesis and release, the enzymes that degrade peptide neurotransmitters are poorly understood. A new study in this issue of the JCI reveals the important role of neuropeptide degradation in regulating obesity (see the related article beginning on page 2291). Wallingford et al. provide evidence that, in mice, the enzyme prolylcarboxypeptidase (PRCP) degrades α-melanocyte–stimulating hormone (α-MSH) to an inactive form that is unable to inhibit food intake. Their studies indicate that PRCP expression promotes obesity, while inhibitors of the enzyme counteract obesity.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(1)
| Title and authors |
Publication |
Year |
Discovery of benzimidazole pyrrolidinyl amides as prolylcarboxypeptidase inhibitors
Hong C. Shen, Fa-Xiang Ding, Changyou Zhou, Yusheng Xiong, Andreas Verras, Renee M. Chabin, Suoyu Xu, Xinchun Tong, Dan Xie, Michael E. Lassman, Urmi R. Bhatt, Margarita M. Garcia-Calvo, Wayne Geissler, Zhu Shen, Dunlu Chen, Ranabir SinhaRoy, Jeffery J. Hale, James R. Tata, Shirly Pinto, Dong-Ming Shen, Steven L. Colletti
|
Bioorganic & Medicinal Chemistry Letters
|
2011 |
|